Hosted on MSN1mon
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Nowthe company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
Hosted on MSN11mon
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competitionthe company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...
--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE ... was primarily driven by an increased demand for our quality control and blood typing products. Currency neutral sales increased in EMEA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results